Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

EQS-News: HSBC doubles EC Healthcare target price to HKD15.00 and reiterates 'Buy' rating EC Healthcare's third advanced imaging service centre commences operation

05/06/2021 | 12:28am EDT
EQS-News / 06/05/2021 / 12:26 UTC+8 
[FOR IMMEDIATE RELEASE] 
 
 
 
HSBC doubles EC Healthcare target price to HKD15.00 and reiterates "Buy" rating 
EC Healthcare's third advanced imaging service centre commences operation 
 
(6 May 2021, Hong Kong) EC Healthcare (the "Company", which together with its subsidiaries is referred to as the 
"Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the 
HSBC Global Research (HSBC) reiterates EC Healthcare's "Buy" rating and doubles the target price to HKD15.00 from 
HKD7.50. 
 
HSBC expects that China's aesthetic medical service market is to double by 2024 on rising acceptance of beauty 
procedures and EC Healthcare is a major beneficiary as it is accelerating its expansion into the Greater Bay Area. The 
Company is particularly well positioned underpinned by the following factors: 
  ? The change of company name reflects the Company's strategy of becoming a leading one-stop medical healthcare 
    service provider in Asia and its rising focus on Mainland China. 
  ? EC Healthcare's fast recovery amid the COVID-19 pandemic and the rebound of contract sales reflect its business 
    resilience and strong execution. 
  ? The expected further relaxation of the cross-border travel quarantine requirements will act as a catalyst. 
  ? HSBC expects the recent M&As to contribute considerably to the estimated 2021 earnings, while the organic expansion 
    of the Company, especially in the medical segment, remains on track. 
  ? HSBC recognized that the introduction of two new strategic investors Dr. Cheng Chi Kong and Aspex Master Fund will 
    provide fresh capital for expansion and suggests potential collaboration. 
 
In addition, the Group's new advanced imaging service center in Tsim Sha Tsui has commenced operation today to 
complement its existing service offerings in Kowloon. The new centre located at Pacific Centre has a gross floor area 
of approximately 3,200 square feet and offers state-of-art advanced imaging services such as Magnetic Resonance Imaging 
(MRI) Scan, Computed Tomography (CT) Scan, X-ray and ultra sound. Together with the two existing advanced imaging 
service centres in Mong Kok and Yuen Long, the total gross floor area of the Group's three advanced imaging service 
centers is approximately 14,000 square feet. 
 
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "Preventive and 
precision medicine has been one of the core business of the Group. To fulfill the demand for advanced imaging services, 
the Group has established relevant service centers through organic growth to achieve further business synergy with 
diversified medical and healthcare business units among the enclosed ecosystem of the Group. We believe the 
aforementioned business expansion will become a growth driver for the Group's business, further consolidating the 
Group's position in the industry as a one-stop comprehensive healthcare and medical service provider, and effectively 
expanding its healthcare and medical market share." 
                                                                     - End - 
 
About EC Healthcare 
EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of 
preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its 
multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer 
services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. 
 
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group 
provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic 
medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics 
jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, New York Spine and 
Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a 
comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, 
a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology 
specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, 
cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories and a professional hair care 
center HAIR FOREST. 
 
*According to an independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020 
 
 
For further information, please contact: 
iPR Ogilvy Limited 
Callis Lau / Shana Li / Ada Chew 
Tel: (852) 2136 6952 / 3920 7649 / 3920 7650 
Fax: (852) 3170 6606 
Email: ech@iprogilvy.com 
File: HSBC doubles EC Healthcare target price to HKD15.00 and reiterates 'Buy' rating 
06/05/2021 Dissemination of a Financial Press Release, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
Media archive at www.todayir.com
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1193111&application_name=news 
 

(END) Dow Jones Newswires

May 06, 2021 00:27 ET (04:27 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -1.58% 33290.08 Delayed Quote.11.20%
HSBC HOLDINGS PLC -2.28% 429.4 Delayed Quote.13.34%
TENCENT HOLDINGS LIMITED 0.67% 603 End-of-day quote.6.91%
Latest news "Companies"
12:26aSUNWAY BERHAD  : Malaysia's Sunway plans stake sale in healthcare business to Singapore's GIC - report
RE
12:07aWORLD BANK ONLINE MORNING SEMINAR #109 “WHAT'S COOKING : Digital Transformation of the Agrifood System”
PU
12:07aPETROPERÚ PETRÓLEOS DEL PER&UACUTE  : Police officers receive biosecurity implements for the protection from COVID-19
PU
12:07aPETROPERÚ PETRÓLEOS DEL PER&UACUTE  : PETROPERÚ presents its main strategic projects to the country's academic sector
PU
06/18The Canadian Labour Congress Passes Resolution Calling on their 3 million Members to Boycott Arterra Wines Products
GL
06/18INVESTOR ALERT : Monteverde & Associates Continues to Investigate the Following Merger
PR
06/18AIRASIA  : joins the people of Bohol in reopening tourism as the official airline carrier of the 2021 Panglao Dive Festival
PU
06/183D SYSTEMS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL : Kahn Swick & Foti, LLC Investigates the Officers and Directors of 3D Systems Corporation - DDD
BU
06/18SHAREHOLDER ALERT : CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GL
06/18SHAREHOLDER ALERT : CLAIMSFILER REMINDS PTON, RLX, UI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GL
Latest news "Companies"